Abstract
Background and Aims: Lipoprotein (a) [LP(a)] is a risk marker for Cardiovascular diseases. Elevated levels of LP(a) are pro-atherogenic and correspond to an increased risk of aortic valve stenosis. Twenty six percent of European population has LP(a) levels of more than 30 mg/dl and have a 3 fold higher risk of developing severe cardiovascular events among patients within 15 years of CABG. Incidence of elevated LP(a) in Pakistan population has not been analyzed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
